Green molecular structure illustration

Supporting a Global HIV Development Program Through Independent IDMC Oversight and Statistical Leadership

1 minute read

Published: November 16th, 2026

As clinical development programmes grow in scale and complexity, sponsors need confidence that safety and efficacy reviews are supported by accurate data, rigorous quality control, and independent statistical expertise. 

In this case study, learn how Phastar supported a global HIV development programme involving multiple studies, repeated IDMC reviews, planned interim analyses, and urgent safety assessments. 

By combining expert statistical programming, independent oversight, and proactive data quality review, our team helped ensure reliable decision-making throughout the programme. 

Download the full case study to discover how Phastar helps sponsors strengthen clinical oversight and support successful global regulatory submissions. 

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...